바로가기 메뉴
본문 바로가기
주메뉴 바로가기
이태승

Tae Seung Lee

Liver, Biliary Tract, and Pancreas Cancer Center

Specialty

Pancreatic diseases, Biliary tract diseases, Pancreatic cancer, Pancreatic tumor, Pancreatic cystic neoplasm (Cysts), Pancreatic neuroendocrine tumor (PNET), Acute and chronic pancreatitis, Pancreatolithiasis, Benign pancreatic disease, Biliary tract cancer, Gallbladder cancer, Cholelithiasis (Gallstones, CBD stones), Cholangitis, Cholecystitis, Gallbladder polyps, Biliary stricture, Gallbladder adenomyomatosis, Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasound (EUS)

Treatment hours

Mon, Tue, Wed, Thur, Fri, Sat
Mon Tue Wed Thu Fri Sat
Education

Completed PhD Course, Internal Medicine, Seoul National University College of Medicine

Master of Medicine, Gyeongsang National University School of Medicine

Bachelor of Science in Biology, Gyeongsang National University

Career

Intern, Seoul National University Hospital

Resident, Internal Medicine, Seoul National University Hospital

Fellow, Gastroenterology, Seoul National University Hospital

Clinical Assistant Professor, Gastroenterology, Seoul National University Hospital


Main Activities

Member, Korean Pancreatobiliary Association

Lifetime Member, Korean Society of Gastrointestinal Endoscopy

Lifetime Member, Korean Society of Gastroenterology

Lifetime Member, Korean Society of Digestive Cancer Research

Lifetime Member, Korean Association of Internal Medicine

Research/Publication

● Interstitial Lung Abnormalities and the Clinical Course in Patients With COPD, Chest. 2021 


● A randomized non-inferiority trial investigating antibiotic adjustments based on blood culture in acute cholangitis, Clinical microbiology and infection. 2025 


● Savolitinib: A Promising Targeting Agent for Cancer, Cancers. 2023 


● Increased needle passes for comparable diagnostic yield in endoscopic ultrasound-guided tissue acquisition for pancreatic stiff lesions measured by elastography, Pancreatology. 2024 


● Are Probiotics Beneficial or Harmful for Pancreatic Cancer Outcomes?, Probiotics Antimicrob Proteins. 2024 


● Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib, Cancers. 2024 


● Digital single-operator cholangioscopy for difficult anastomotic biliary strictures in living donor liver transplantation recipients after failure of standard ERCP: SPYPASS-2 study, Gastrointestinal Endoscopy. 2024 


● Diagnostic performance of EUS-guided elastography for differential diagnosis of gallbladder polyp, Gastrointestinal Endoscopy. 2024 


● Endoscopic hemostasis with a self-expandable metal stent as bridge therapy for hemobilia, Endoscopy International Open. 2025 


● Comparison of 5-Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer, Journal of Gastroenterology and Hepatology. 2025